REVVITY, INC Equity Securities without Readily Determinable Fair Value, Upward Price Adjustment, Annual Amount
REVVITY, INC (RVTY) reported Equity Securities without Readily Determinable Fair Value, Upward Price Adjustment, Annual Amount of $2.90 million for the 12-month period ending 2023-01-01, per its 10-K filed 2023-03-01.
Discontinued › Notes › Investments
us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueUpwardPriceAdjustmentAnnualAmount · last filed 2023-03-01
- REVVITY, INC equity securities without readily determinable fair value, upward price adjustment, annual amount for fiscal 2023 was $2.90M, a 85.20% decline from fiscal 2022.
- REVVITY, INC equity securities without readily determinable fair value, upward price adjustment, annual amount for fiscal 2022 was $19.60M, a 48900.00% increase from fiscal 2021.
- REVVITY, INC equity securities without readily determinable fair value, upward price adjustment, annual amount for fiscal 2021 was $40.00K, a 99.51% decline from fiscal 2019.
- REVVITY, INC equity securities without readily determinable fair value, upward price adjustment, annual amount for fiscal 2019 was $8.20M.
| Period end | Equity Securities without Readily Determinable Fair Value, Upward Price Adjustment, Annual Amount 12 month | Equity Securities without Readily Determinable Fair Value, Upward Price Adjustment, Annual Amount 12 month as first filed |
|---|---|---|
| 2023-01-01 | $2.90M 10-K · filed 2023-03-01 | |
| 2022-01-02 | $19.60M 10-K · filed 2023-03-01 | |
| 2021-01-03 | $40.00K 10-K · filed 2022-03-03 | $35.00K 10-K · filed 2021-03-02 |
| 2019-12-29 | $8.20M 10-K · filed 2022-03-03 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Avantor, Inc. (AVTR) | United States | $10.501B | -9.72 |
| BRUKER CORP (BRKR) | United States | $9.706B | -128.75 |
| METTLER TOLEDO INTERNATIONAL INC/ (MTD) | $30.436B | 30.62 | |
| Alamar Biosciences, Inc. (ALMR) | United States | $2.300B | |
| Cytek Biosciences, Inc. (CTKB) | United States | $0.744B | -7.15 |
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) | United States | $0.491B | -3.95 |
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |
| EyePoint, Inc. (EYPT) | United States | $0.314B | -3.96 |
| Quanterix Corp (QTRX) | United States | $0.150B | -1.65 |
| Nautilus Biotechnology, Inc. (NAUT) | United States | $0.129B | -4.16 |